Dyne Therapeutics, Inc.
NASDAQDyne Therapeutics fell 13% on the week to $15.92 — yet options traders are suddenly the most bullish they've been all year. The options signal is the sharpest thing in this week's data. The put/call ratio collapsed to 1.21, nearly three standard deviations below its 20-day average of 2.27. That's the lowest PCR reading in the past year, against a 52-week low of 0.22 and a high of…
Snapshot as of 21 May 2026
Dyne Therapeutics fell 13% on the week to $15.92 — yet options traders are suddenly the most bullish they've been all year. The options signal is the sharpest thing in this week's data. The put/call ratio collapsed to…
DYN posted a better-than-expected Q1 this week, and the 5.2% weekly gain shows investors noticed. The real question now is whether a narrowing loss and a fresh analyst nudge from Bernstein are enough to dent a short…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for DYN — free to start on ORTEX.
Sign up for free →Open DYN on ORTEX